Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ADC Therapeutics (ADCT) Debt Ratio (2021 - 2026)

ADC Therapeutics has reported Debt Ratio over the past 6 years, most recently at 0.4 for Q1 2026.

  • Quarterly results put Debt Ratio at 0.4 for Q1 2026, down 4.96% from a year ago — trailing twelve months through Mar 2026 was 0.4 (down 4.96% YoY), and the annual figure for FY2025 was 0.36, up 1.23%.
  • Debt Ratio reached 0.4 in Q1 2026 per ADCT's latest filing, up from 0.36 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.42 in Q1 2025 and bottomed at 0.3 in Q4 2022.
  • Median Debt Ratio over the past 5 years was 0.36 (2025), compared with a mean of 0.35.
  • The largest annual shift saw Debt Ratio soared 67.34% in 2022 before it fell 4.96% in 2026.
  • Over 5 years, Debt Ratio stood at 0.3 in 2022, then increased by 7.04% to 0.32 in 2023, then increased by 11.1% to 0.35 in 2024, then rose by 1.23% to 0.36 in 2025, then increased by 11.08% to 0.4 in 2026.
  • Business Quant data shows Debt Ratio for ADCT at 0.4 in Q1 2026, 0.36 in Q4 2025, and 0.4 in Q3 2025.